Nature Communications (Nov 2022)

FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation

  • Joshua I. Warrick,
  • Wenhuo Hu,
  • Hironobu Yamashita,
  • Vonn Walter,
  • Lauren Shuman,
  • Jenna M. Craig,
  • Lan L. Gellert,
  • Mauro A. A. Castro,
  • A. Gordon Robertson,
  • Fengshen Kuo,
  • Irina Ostrovnaya,
  • Judy Sarungbam,
  • Ying-bei Chen,
  • Anuradha Gopalan,
  • Sahussapont J. Sirintrapun,
  • Samson W. Fine,
  • Satish K. Tickoo,
  • Kwanghee Kim,
  • Jasmine Thomas,
  • Nagar Karan,
  • Sizhi Paul Gao,
  • Timothy N. Clinton,
  • Andrew T. Lenis,
  • Timothy A. Chan,
  • Zhiyu Chen,
  • Manisha Rao,
  • Travis J. Hollman,
  • Yanyun Li,
  • Nicholas D. Socci,
  • Shweta Chavan,
  • Agnes Viale,
  • Neeman Mohibullah,
  • Bernard H. Bochner,
  • Eugene J. Pietzak,
  • Min Yuen Teo,
  • Gopa Iyer,
  • Jonathan E. Rosenberg,
  • Dean F. Bajorin,
  • Matthew Kaag,
  • Suzanne B. Merrill,
  • Monika Joshi,
  • Rosalyn Adam,
  • John A. Taylor,
  • Peter E. Clark,
  • Jay D. Raman,
  • Victor E. Reuter,
  • Yu Chen,
  • Samuel A. Funt,
  • David B. Solit,
  • David J. DeGraff,
  • Hikmat A. Al-Ahmadie

DOI
https://doi.org/10.1038/s41467-022-34251-3
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 17

Abstract

Read online

Bladder cancer can often exhibit genomic and morphological heterogeneity. Here, the authors use genomics analysis to show lineage plasticity of bladder cancers with squamous differentiation, and identify key transcription factors related to this morphological and immune heterogeneity.